Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript November 3, 2023 Oncolytics Biotech Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $-0.07. Operator: Good morning, and welcome to Oncolytics Biotech’s Third Quarter 2023 Conference Call. All participants are now in listen-only mode. There will be a question-and-answer session at the […]

Related Keywords

Canada , Canadian , Thomas Heineman , Matt Coffey , Roche Incyte , Tom Heineman , European Society For Medical Oncology , Oil Refinery Stocks To , Global Head Of Business Development , Chief Medical Officer , Global Head , Business Development , Andrew De Guttadauro , Chief Financial Officer , Kirk Look , European Society , Medical Oncology , Registrational Trials , Precision Promise Phase , Chief Medical , Precision Promise , Registrational Studies , Oil Refinery Stocks To Buy , Small Cap Biotech Stocks , Massive Potential According , Pancreatic Cancer , Olorectal , Breast Cancer , Oncolytics Biotech Inc , Colorectal Cancer , Financial Results , Metastatic Breast Cancer , Oncolytics Biotech , Poblet , Mechanism Of Action , Linical Studies , Dancer ,